We come up in the market with an objective to cater diverse needs of clients by offering the best quality Oxaliplatin Injection. The provided product is injected into patients body who are suffering from colon and rectal cancer. Under the stringent observation of dexterous professionals, this injection is formulated with the use of sophisticated methodology. Prior to packaging procedure, the offered Oxaliplatin Injection is rigorously checked on quality parameters to ensure its high effectiveness.
Each vial contains:- Oxaliplatinâ€¦.. 2 mg per ml
Pack Size:-25ml , 50 ml
Oxaliplatin is a neoplastic drug used in metastatic colorectal cancer where fluropyrimidines therapy or alone chemotherapy have failed, also used along with fluropyrimidines.
|Composition :|| Each vial contains:
Each vial contains:
Oxaliplatin -------------------25mg, 50mg, 100mg
Water for injection -----------q.s.
|Indications :|| oxaliplatin used in combination with infusional 5-fluorouracil/leucovorin, is indicated for:
â€¢ adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor.
treatment of advanced colorectal cancer.
|Contraindications :|| Oxaliplatin should not be administered to patients with a history of known allergy to oxaliplatin or other platinum compounds .
|Adverse Effects :||Serious adverse reactions including anaphylaxis and allergic reactions, neuropathy,pulmonary toxicities and hepatotoxicities can occur..|
|Dosage :|| oxaliplatin 85 mg/mÂ² intravenous infusion in 250-500 mL 5% Dextrose injection, USP and leucovorin 200 mg/mÂ² intravenous infusion in 5% Dextrose Injection, USP both given over 120 minutes at the same time in separate bags using a Y-line, followed by 5-fluorouracil 400 mg/mÂ² intravenous bolus given over 2-4 minutes, followed by 5-fluorouracil 600 mg/mÂ² intravenous infusion in 500 mL 5% Dextrose Injection, USP (recommended) as a 22-hour continuous infusion.
Day 2: Leucovorin 200 mg/mÂ² intravenous infusion over 120 minutes, followed by 5-fluorouracil 400 mg/mÂ² intravenous bolus given over 2-4 minutes, followed by 5-fluorouracil 600 mg/mÂ² intravenous infusion in 500 mL 5% Dextrose Injection, USP (recommended) as a 22-hour continuous infusion.
|Pharmacological action :|| Oxaliplatin is a neoplastic drug used in metastatic colorectal cancer where fluropyrimidines therapy or alone chemotherapy have failed, also used along with fluropyrimidines.
Precautions : Oxaliplatin may rarely cause a severe (possibly fatal) allergic reaction within minutes after a dose. Tell your doctor immediately if you develop any signs of an allergic reaction (e.g., rash, itching, swelling, trouble breathing, dizziness)..
|Drug interaction:||No pharmacokinetic interaction between 85 mg/mÂ² of Oxaliplatin and infusional 5-fluorouracil has been observed in patients treated every 2 weeks, but increases of 5-fluorouracil plasma concentrations by approximately 20% have been observed with doses of 130 mg/mÂ² of Oxaliplatin administered every 3 weeks. In vitro, platinum was not displaced from plasma proteins by the following medications: erythromycin, salicylate, sodium valproate, granisetron, and paclitaxel. In vitro, oxaliplatin is not metabolized by, nor does it inhibit, human cytochrome P450 isoenzymes. No P450-mediated drug-drug interactions are therefore anticipated in patients..|
|Precautions:||Oxaliplatin may rarely cause a severe (possibly fatal) allergic reaction within minutes after a dose.|
We are affianced in providing the best services to our client. Our top-notch quality Cytarabine Injection is used to treat cancer by preventing the growth of cancer cells. The provided injection is processed and tested with the aid of sophisticated methodology.
Cytarabine belongs to the group of medicines called antimetabolites which acts by inhibiting DNA polymerase. Particularly, it blocks the progression of cells from the G1 phase to the S-phase.
It is indicated in patients with acute Non-Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, Acute Lymphoblastic Leukaemia, Diffuse Histiocytic Lymphomas (non-Hodgkin's lymphomas of high malignancy), Acute Lymphocytic Leukaemia, Erythroleukemia, Blast Crisis of Chronic Myeloid Leukaemia, Meningeal Leukaemia and Meningeal Neoplasms.
It is strictly recommended that after being treated with cytarabine, do take immunizations (vaccinations) without your doctor's instruction.
Cytarabine Injection is contraindicated in patients who have hypersensitivity to this drug.
Take immediate medical attention if you observe any of these side effects like hives, difficult breathing; swelling of face, lips, tongue or throat, fever with nausea, vomiting, problems with your vision or hearing, loss of movement in any part of body, loss of bowel or bladder control, pale skin, lightheadedness and shortness of breath etc.
We are incepted in manufacturing high-grade Cyclophosphamide Injections using advanced methodology. The offered injection is processed and tested under the under the strict supervision of ingenious professionals.
Cyclophosphamide belongs to the group of cancer medicines called alkylating agents which have potent anticancer activity. Cyclophosphamide binds to one of the cancer cell’s DNA strands and hinders the growth of cancer cells. It is used to treat various types of cancers in body like breast, blood, ovaries, lymph system and nerves (mostly in children). It is also used in treating mycosis fungoides (tumors on the skin), retinoblastoma (a type of eye cancer primarily in children) and multiple myeloma (cancer in the bone marrow). It is also sometimes used to treat a certain type of lung cancer (small cell lung cancer; SCLC), rhabdomyosarcoma (a type of cancer of the muscles) and Ewing's sarcoma (a type of bone cancer) in children.
Before starting the treatment with Cyclophosphamide, discuss with your doctor about the benefits of this medicine as well as the risks of using it.
Tell your doctor if you have previously received any chemotherapy treatment or if you have x-rays recently, any kidney or liver disease.
Use of Cyclophosphamide is contraindicated in patients are allergic to it or other alkylating agents such as bendamustine, busulfan, Busulfex, carmustine, chlorambucil, any other medications or any of the ingredients in cyclophosphamide injection. Anaphylactic reactions that occur due to hypersensitivity reactions may cause death. It is also contraindicated in patients with urinary tract outflow obstruction and third trimester of pregnancy.
Visit your doctor immediately if one feels cough or hoarseness, fever or chills, lower back or side pain, missing menstrual periods, painful or difficult urination, blood in the urine, fast heartbeat, shortness of breath, unusual tiredness or weakness etc.
With an objective to serve clients in best possible manner, we have been betrothed in providing high quality Leuprolide Injection. This injection is ideal for the treatment of anemia. The offered injection is available in medical stores, hospitals and other similar places. The offered injection is formulated at modern processing unit by our adept professionals using high grade chemicals. In addition to this, the provided Leuprolide Injection can be bought from us in moisture proof packaging at cost effective rates.
Key Points:Longer shelf life Safe and reliable Quick acting Accurate composition
Composition- : Each 0.5ml Contains : Leuprolide Acetate 1mg
Leuprolide acts as an agonist at pituitary GnRH receptors. By interrupting the normal pulsatile stimulation and the desensitization of the GnRH receptors; it indirectly down regulates the secretion of gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH) leading to hypogonadism and thus a dramatic reduction in estradiol .
|Specification-||pH range â€“ : 5.5 to 6.5
Leuprolide acetate is a synthetic nonapeptide analog of naturally occurring gonadotropin releasing hormone (GnRH or LH-RH). The analog possesses greater potency than the natural hormone. It is a sterile, aqueous solution intended for subcutaneous injection.
|Indication :||Advanced prostatic carcinoma when orchidectomy or oestrogen administration is not indicated.|
|Dosage :-||SC inj., 1 mg single dose.|
|Contraindications:-||Pregnancy, in women who may become pregnant while receiving the drug, and during lactation. Sensitivity to benzyl alcohol (found in leuprolide injection). Undiagnosed abnormal vaginal bleeding. Hypersensitivity to GnRH or GnRH agonist analogs. The 30-mg depot in women.|
|Precautions:-||Patients with metastatic vertebral lesions and/or with urinary tract obstruction should be closely observed during the first few weeks of therapy. Patients with known allergies to benzyl alcohol, an ingredient of the drug's vehicle, may present symptoms of hypersensitivity, usually local, in the form of erythema and induration at the injection site.|
|Drug interaction:||Administration of leuprolide acetate in therapeutic doses results in suppression of the pituitary-gonadal system. Normal function is usually restored within 4 to 12 weeks after treatment is discontinued. Administration of leuprolide acetate in therapeutic doses results in suppression of the pituitary-gonadal system. Normal function is usually restored within 4 to 12 weeks after treatment is discontinued.|
|Adverse Effect-:||High blood pressure, ischemia, insomnia, constipation, urinating more often than usual, bone pain, loss of movement in any part of your body; swelling, rapid weight gain.|
|Storage:||: Store unopened bottles in the refrigerator. Vials can be kept at room temperature (less than 86 degrees F or 30 degrees C). Do not freeze. Protect from light.|